Figure 2.
Actuarial curves of patients free from gastroesophageal rebleeding after distal spleno-renal shunt (DSRS) and endoscopic sclerotherapy (ES). P < 0.05 vs ES using the log-rank test.
Actuarial curves of patients free from gastroesophageal rebleeding after distal spleno-renal shunt (DSRS) and endoscopic sclerotherapy (ES). P < 0.05 vs ES using the log-rank test.